A new mutation (Leu569Arg) within exon 13 of the TGFBI (BIGH3) gene causes lattice corneal dystrophy type I

John F. Warren, Richard L. Abbott, Michael K. Yoon, J. Brooks Crawford, William H. Spencer, Todd P. Margolis

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

PURPOSE: To describe an American family with lattice corneal dystrophy type I, which associates with a novel mutation, Leu569Arg, of the TGFBI (BIGH3) gene. DESIGN: Experimental study. METHODS: Genomic DNA was extracted from buccal epithelial cells of four affected members of an American family with lattice corneal dystrophy type I. All 17 exons of the TGFBI gene were evaluated by PCR amplification and direct sequencing. Clinical and histologic data were also collected. RESULTS: Three generations of this family have been positively diagnosed with lattice corneal dystrophy, indicating autosomal dominant inheritance. We identified a heterozygous point mutation that associates with the disease phenotype. The single base-pair substitution (T1753G) results in an amino acid substitution (Leu569Arg) in exon 13 of the TGFBI gene. CONCLUSIONS: Substitution of arginine for leucine at position 569 of the TGFBI gene results in a form of lattice corneal dystrophy that is phenotypically similar to other genetically distinct forms of type I disease. This is the first report of disease correlated with changes in exon 13 of the TGFBI gene.

Original languageEnglish
Pages (from-to)872-878
Number of pages7
JournalAmerican journal of ophthalmology
Volume136
Issue number5
DOIs
StatePublished - Nov 2003
Externally publishedYes

Fingerprint Dive into the research topics of 'A new mutation (Leu569Arg) within exon 13 of the TGFBI (BIGH3) gene causes lattice corneal dystrophy type I'. Together they form a unique fingerprint.

  • Cite this